Abbott Laboratories (ABT) Operating Leases (2019 - 2021)

Abbott Laboratories has disclosed Operating Leases across 3 years of filings, most recently posting $956.0 million for Q4 2021.

• In Q4 2021, Operating Leases rose 5.99% year-over-year to $956.0 million; the TTM figure through Dec 2021 stood at $956.0 million (up 5.99% YoY), while the FY2021 annual figure was $956.0 million, up 5.99% from the prior year.
• Operating Leases came in at $956.0 million for Q4 2021 at Abbott Laboratories, up from $902.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $956.0 million in Q4 2021 to a low of $755.0 million in Q4 2019.
• Average Operating Leases over 3 years is $871.0 million, with a median of $902.0 million recorded in 2020.
• Year-over-year, Operating Leases advanced 19.47% in 2020 and grew 5.99% in 2021.
• Over 3 years, Operating Leases stood at $755.0 million in 2019, then climbed by 19.47% to $902.0 million in 2020, then gained by 5.99% to $956.0 million in 2021.
• Per Business Quant data, the three most recent Operating Leases figures were $956.0 million in Q4 2021, $902.0 million in Q4 2020, and $755.0 million in Q4 2019.